NCT05081999View on ClinicalTrials.gov

De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

8,500

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Stable Ischemic Heart DiseaseCoronary Artery DiseaseBeta-blocker Therapy
Interventions
OTHER

Medical Assessment

medical hx, events inquiry, adherence to treatment arm periodically over 4 years

OTHER

Quality of Life Assessment

online questionnaires periodically over 4 years, including SAQ, EQ-5D-5L, IIEF-5 (males) or FSFI (females)

Trial Locations (1)

T6G 2B7

RECRUITING

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER